Literature DB >> 22469616

Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.

Thomas Kristensen1, Sigurd Broesby-Olsen, Hanne Vestergaard, Carsten Bindslev-Jensen, Michael B Møller.   

Abstract

It is presently accepted that the KIT D816V mutation is detectable in tissues with neoplastic mast cells in most patients with indolent systemic mastocytosis. In this study, neoplastic mast cells were detected in bone marrow, but not in peripheral blood, by flow cytometry in all 25 included cases of indolent systemic mastocytosis. However, the KIT D816V mutation was detected using mutation-specific qPCR in both bone marrow and peripheral blood in all 25 cases, demonstrating for the first time that the KIT D816V mutation is consistently present in non-mast cells in indolent systemic mastocytosis and that these cells are circulating in peripheral blood.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469616     DOI: 10.1111/j.1600-0609.2012.01789.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  9 in total

1.  Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.

Authors:  Janine Altmüller; Britta Haenisch; Amit Kawalia; Markus Menzen; Markus M Nöthen; Heide Fier; Gerhard J Molderings
Journal:  Immunogenetics       Date:  2017-04-06       Impact factor: 2.846

2.  Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.

Authors:  Maria Jara-Acevedo; Cristina Teodosio; Laura Sanchez-Muñoz; Ivan Álvarez-Twose; Andrea Mayado; Carolina Caldas; Almudena Matito; José M Morgado; Javier I Muñoz-González; Luis Escribano; Andrés C Garcia-Montero; Alberto Orfao
Journal:  Mod Pathol       Date:  2015-06-12       Impact factor: 7.842

Review 3.  Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.

Authors:  Britta Haenisch; Markus M Nöthen; Gerhard J Molderings
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

Review 4.  Clinical Validation of KIT Inhibition in Advanced Systemic Mastocytosis.

Authors:  John H Baird; Jason Gotlib
Journal:  Curr Hematol Malig Rep       Date:  2018-10       Impact factor: 3.952

Review 5.  Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

Authors:  Peter Valent; Cem Akin; Karin Hartmann; Gunnar Nilsson; Andreas Reiter; Olivier Hermine; Karl Sotlar; Wolfgang R Sperr; Luis Escribano; Tracy I George; Hanneke C Kluin-Nelemans; Celalettin Ustun; Massimo Triggiani; Knut Brockow; Jason Gotlib; Alberto Orfao; Lawrence B Schwartz; Sigurd Broesby-Olsen; Carsten Bindslev-Jensen; Petri T Kovanen; Stephen J Galli; K Frank Austen; Daniel A Arber; Hans-Peter Horny; Michel Arock; Dean D Metcalfe
Journal:  Cancer Res       Date:  2017-03-02       Impact factor: 12.701

6.  The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease.

Authors:  G Hoermann; K V Gleixner; G E Dinu; M Kundi; G Greiner; F Wimazal; E Hadzijusufovic; G Mitterbauer; C Mannhalter; P Valent; W R Sperr
Journal:  Allergy       Date:  2014-04-17       Impact factor: 13.146

Review 7.  KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Authors:  M Arock; K Sotlar; C Akin; S Broesby-Olsen; G Hoermann; L Escribano; T K Kristensen; H C Kluin-Nelemans; O Hermine; P Dubreuil; W R Sperr; K Hartmann; J Gotlib; N C P Cross; T Haferlach; A Garcia-Montero; A Orfao; J Schwaab; M Triggiani; H-P Horny; D D Metcalfe; A Reiter; P Valent
Journal:  Leukemia       Date:  2015-02-04       Impact factor: 11.528

Review 8.  Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis.

Authors:  Boguslaw Nedoszytko; Michel Arock; Jonathan J Lyons; Guillaume Bachelot; Lawrence B Schwartz; Andreas Reiter; Mohamad Jawhar; Juliana Schwaab; Magdalena Lange; Georg Greiner; Gregor Hoermann; Marek Niedoszytko; Dean D Metcalfe; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923

Review 9.  Systemic Mastocytosis: Molecular Landscape and Implications for Treatment.

Authors:  Cecilia Monaldi; Sara De Santis; Manuela Mancini; Samantha Bruno; Michele Cavo; Simona Soverini
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.